Page 21 - AN-3-1
P. 21

Advanced Neurology                                                  PSD-95 in neurodevelopmental disorders



               doi: 10.1016/j.neubiorev.2022.104596               neurons. Mol Cell Neurosci. 2006;32(4):356-365.
            57.  da Silva BS, Grevet EH, Silva LCF, Ramos JKN, Rovaris DL,      doi: 10.1016/j.mcn.2006.05.007
               Bau CHD. An overview on neurobiology and therapeutics   68.  Park SW, Lee CH, Cho HY, et al. Effects of antipsychotic
               of attention-deficit/hyperactivity disorder.  Discov Ment   drugs on the expression of synaptic proteins and dendritic
               Health. 2023;3(1):2.
                                                                  outgrowth in hippocampal neuronal cultures.  Synapse.
            58.  del Campo N, Chamberlain SR, Sahakian BJ, Robbins TW. The   2013;67(5):224-234.
               roles of dopamine and noradrenaline in the pathophysiology      doi: 10.1002/syn.21634
               and treatment of attention-deficit/hyperactivity disorder.
               Biol Psychiatry. 2011;69(12):e145-e157.         69.  Takaki M, Kodama M, Mizuki Y,  et  al. Effects of the
                                                                  antipsychotics haloperidol, clozapine, and aripiprazole
               doi: 10.1016/j.biopsych.2011.02.036
                                                                  on the dendritic spine.  Eur Neuropsychopharmacol.
            59.  Yao WD, Gainetdinov RR, Arbuckle MI, et al. Identification   2018;28(5):610-619.
               of  PSD-95  as  a  regulator  of  dopamine-mediated  synaptic      doi: 10.1016/j.euroneuro.2018.03.004
               and behavioral plasticity. Neuron. 2004;41(4):625-638.
                                                               70.  Leucht S, Cipriani A, Spineli L,  et al. Comparative
               doi: 10.1016/s0896-6273(04)00048-0
                                                                  efficacy and tolerability of 15 antipsychotic drugs in
            60.  Wang LJ, Yu YH, Fu ML, et al. Attention deficit–hyperactivity   schizophrenia: A multiple-treatments meta-analysis. Lancet.
               disorder is associated with allergic symptoms and low levels   2013;382(9896):951-962.
               of hemoglobin and serotonin. Sci Rep. 2018;8(1):10229.
                                                                  doi: 10.1016/S0140-6736(13)60733-3
               doi: 10.1038/s41598-018-28702-5
                                                               71.  Urs NM, Peterson SM, Caron MG. New concepts in
            61.  Bauer  J,  Werner A,  Kohl  W,  et al. Hyperactivity and   dopamine D2 receptor biased signaling and implications for
               impulsivity in adult attention-deficit/hyperactivity disorder   schizophrenia therapy. Biol Psychiatry. 2017;81(1):78-85.
               is related to glutamatergic dysfunction in the anterior      doi: 10.1016/j.biopsych.2016.10.011
               cingulate cortex. World J Biol Psychiatry. 2018;19(7):538-546.
                                                               72.  Singh KK, De Rienzo G, Drane L, et al. Common DISC1
               doi: 10.1080/15622975.2016.1262060
                                                                  polymorphisms disrupt Wnt/GSK3β signaling and brain
            62.  Bollmann S, Ghisleni C, Poil SS, et al. Developmental changes   development. Neuron. 2011;72(4):545-558.
               in  gamma-aminobutyric  acid  levels  in  attention-deficit/     doi: 10.1016/j.neuron.2011.09.030
               hyperactivity disorder. Transl Psychiatry. 2015;5(6):e589.
                                                               73.  Mao Y, Ge X, Frank CL, et al. Disrupted in schizophrenia 1
               doi: 10.1038/tp.2015.79
                                                                  regulates neuronal progenitor proliferation via modulation
            63.  Cheng J, Liu A, Shi MY, Yan Z. Disrupted glutamatergic   of GSK3β/β-catenin signaling. Cell. 2009;136(6):1017-1031.
               transmission in prefrontal cortex contributes to      doi: 10.1016/j.cell.2008.12.044
               behavioral abnormality in an animal model of ADHD.
               Neuropsychopharmacol. 2017;42(10):2096-2104.    74.  Wang CX, Song JH, Song DK, Yong VW, Shuaib A, Hao C.
                                                                  Cyclin-dependent kinase-5 prevents neuronal  apoptosis
               doi: 10.1038/npp.2017.30
                                                                  through ERK-mediated upregulation of Bcl-2.  Cell Death
            64.  Kotecha SA, Oak JN, Jackson MF,  et al. A  D2 class   Differ. 2006;13(7):1203-1212.
               dopamine receptor transactivates a receptor tyrosine      doi: 10.1038/sj.cdd.4401804
               kinase to inhibit NMDA receptor transmission.  Neuron.
               2002;35(6):1111-1122.                           75.  de Bartolomeis A, Vellucci L, De Simone G, Mazza  B,
                                                                  Barone  A, Ciccarelli M. Dysregulated signaling at
               doi: 10.1016/s0896-6273(02)00859-0
                                                                  postsynaptic density: A systematic review and translational
            65.  Yuen EY, Zhong P, Yan Z. Homeostatic regulation of   appraisal for the pathophysiology, clinics, and antipsychotics’
               glutamatergic transmission by dopamine D4 receptors. Proc   treatment of schizophrenia. Cells. 2023;12(4):574.
               Natl Acad Sci U S A. 2010;107(51):22308-22313.
                                                                  doi: 10.3390/cells12040574
               doi: 10.1073/pnas.1010025108
                                                               76.  Iasevoli F, Ambesi-Impiombato A, Fiore G, Panariello F,
            66.  Swann JW, Le JT, Lam TT, Owens J, Mayer AT. The impact   Muscettola G, de Bartolomeis A. Pattern of acute induction
               of chronic network hyperexcitability on developing   of Homer1a gene is preserved after chronic treatment with
               glutamatergic synapses. Eur Neurosci. 2007;26(4):975-991.  first-and second-generation antipsychotics: Effect of short-
                                                                  term drug discontinuation and comparison with Homer1a-
               doi: 10.1111/j.1460-9568.2007.05739.x
                                                                  interacting genes. J Psychopharmacol. 2011;25(7):875-887.
            67.  Critchlow HM, Maycox PR, Skepper JN, Krylova O.
               Clozapine and haloperidol differentially regulate dendritic      doi: 10.1177/0269881109358199
               spine formation and synaptogenesis in rat hippocampal   77.  Pithadia AB, Jain SM. 5-Hydroxytryptamine receptor


            Volume 3 Issue 1 (2024)                         15                        https://doi.org/10.36922/an.2095
   16   17   18   19   20   21   22   23   24   25   26